INTRODUCTION {#PAN_2020_v24n2_22_sec1}
============

Non-communicable diseases, as chronic diseases, account for 70% of the mortality rates worldwide, while communicable diseases cause the remaining 30%. Among non-communicable diseases, those with high mortality rates include cancer, diabetes, cardiovascular disease, and lung disease. Cancer is classified as a fatal disease for patients because it is difficult to cure owing to its rapid growth, and is highly likely to spread throughout the body through blood or lymphatic fluid. In particular, reduction of female physical activity due to various social environments is a potential cause of increased breast cancer incidence. In addition, the most frequent characteristic of breast cancer among women is not only high incidence, but also high efficiency of cancer treatment. Although the effectiveness of anti-cancer drugs is very high for breast cancer patients, a lot of pain, caused by chemotherapy, accompanies it. Therefore, there is an urgent need to improve the survival rate of breast cancer patients, and improve the quality of life during chemotherapy treatment. Recently, various preclinical studies have suggested that exercise attenuates tumor growth and tumorigenesis ([Table 1](#PAN_2020_v24n2_22_T1){ref-type="table"}). However, molecular mechanisms by which exercise affects cancer progression are not yet clear. In this review, we aimed to summarize studies on exercise methods that could potentially increase the survival rate of breast cancer patients and suppress cancer progression.

###### Changes in blood variables before exercise and during post-exercise period.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mouse\        Mouse            Induction                      Exercise     Protocols                       Test                              Efficacy & Signal pathways              Ref
  model                                                                                                                                                                                
  ------------- ---------------- ------------------------------ ------------ ------------------------------- --------------------------------- --------------------------------------- -----
  Xenograft     NMRI-Foxn1^nu^   MCF-7 cell\                    Running      Voluntary wheel\                -Tumor growth\                    \- MCF-7 (--36%, P \<0.05) and\         4
                                 (ER^+^, PR^+^, HER2^-^)\                    running\                        - To evaluate the\                MDA-MB-231 (--66%, P \<\                
                                 MDA-MB-231 cell\                            (4 km per night/cage)           effect of exercise-conditioned\   0.01) tumor growth\                     
                                 \                                                                           serum in\                         - Regulating Hippo signaling\           
                                 (ER^-^, PR^-^, HER2^-^)                                                     cancer cell                       (ANKRD1 and CTGF)                       

  Orthotopic    FVB/NJ           p53/PTEN\                      Stretching   Treated for 10 minutes\         Tumor growth                      52% reduced tumor size                  5
                                 double-null (−/−)\                          once a day, for four\                                                                                     
                                 primary cell                                weeks                                                                                                     

  Xenograft     Female BALB/c    MC4-L2 cell\                   Running      Using the treadmill;\           \- Tumor volume\                  \- Decrease tumor volume and\           6
                                 (ER^+^, PR^+^)                              After acclimation, the\         - mRNA expression &\              weight\                                 
                                                                             interval exercise training\     Protein expression                \                                       
                                                                             protocol commenced\                                               - Reduced PI3K/AKT and\                 
                                                                             at 16--18 m min−1, 0%\                                            ERK activation ; Induced\               
                                                                             gradient, for 10−14 min,\                                         Apoptosis                               
                                                                             5 days each week for 6\                                                                                   
                                                                             weeks, and the exercise\                                                                                  
                                                                             intensity was gradually\                                                                                  
                                                                             increased each week                                                                                       

  Orthotopic    Female\          E0771 cell\                    Running      Voluntary wheel running         \- Tumor growth &\                \- Increasing log phase tumor\          7
                APOE^-/-^        (ER^+^, PR^+^, HER2^+^)                                                     metastasis\                       growth and inhibiting metastasis\       
                                                                                                             \                                 \                                       
                                                                                                             - Property of tumor               - Reduced tumor hypoxia affect\         
                                                                                                                                               exponential tumor growth\               
                                                                                                                                               in APOE^-/-^mice                        

  Orthotopic    Female FVB/NJ\   C3(1)SV40Tag\                  Running      Using the treadmill;\           -Tumor growth\                    \- 771 (0.5 folds), C3(1)\              8
                Female BALB/c\   -p-16-lu cell\                              After acclimation, 5 m/\        \                                 SV40Tag-p16-lu cell (2 folds),\         
                Female C57/BL6   (Claudin-low\                               min for 5 min, 10 m/min.\       - Gene expression                 4T07 cell ( same size) tumor\           
                                 breast cancer)\                             for 5 min, 15 m/min for\                                          size\                                   
                                 \                                           5 min., and 20 m/min.\                                            - Ki67 expressions : E0771\             
                                 E0771 cell\                                 for 45 min., which is\                                            (0.25 folds), C3(1)SV40Tagp16-\         
                                 \                                           equivalent to 70% VO2\                                            lu cell (1.26 folds), 4T07\             
                                 4T07 cell\                                  peak.\                                                            cell (same expression)\                 
                                 (ER^-^, PR^-^, HER2^-^)                     The exercise intensity\                                           - Hif1-α expressions :E0771\            
                                                                             was gradually increased\                                          (-5.0 folds), C3(1)SV40Tagp16-\         
                                                                             each week for 2 weeks                                             lu cell (11.0 folds), 4T07\             
                                                                                                                                               cell (same expression)                  

  Orthotopic    Female\          4T1 cell\                      Running      Wheels (running group)\         -Tumor growth, perfusion,\        -Statistically significantly reduced\   9
                C57/BL6          (ER^-^, PR^-^, HER2^-^)\                    vs. without Wheels\             hypoxia, and\                     tumor growth and was\                   
                                 \                                           (sedentary group)               components of the\                associated with a 1.4-fold\             
                                 E0771 cell                                                                  antigenic and apoptotic\          increase in apoptosis                   
                                                                                                             cascades                                                                  

  Xenograft     Female\          4T1 cell                       Running      Using the treadmill (18\        -Tumor growth\                    \- Exercise regulates tumor\            10
                BALB/c                                                       m/min for 30 min once\          \                                 growth through immune cells\            
                                                                             a day) vs. sedimentary\         -Evaluating immune\               responses\                              
                                                                             group for 30 days               cell ratio                        \                                       
                                                                                                                                               - Exercise with radiotherapy\           
                                                                                                                                               reduces MDSCs accumulation\             
                                                                                                                                               and NK cell activation                  

  Orthotopic    Female\          4T1 cell                       Running      Low intensity exercise (6\      \- Tumor growth\                  \- HE inhibited tumor growth\           11
                BALB/c                                                       m/min, 60 min/d) group\         \                                 \                                       
                                                                             (LE),\                          -Evaluating apoptosis\            - HE combined with administration\      
                                                                             \                               signals                           of didzein induces\                     
                                                                             Medium intensity exercise\                                        apoptosis of breast cancer              
                                                                             (10 m/min, 60 min/\                                                                                       
                                                                             d) group (ME),\                                                                                           
                                                                             \                                                                                                         
                                                                             High intensity exercise\                                                                                  
                                                                             (15 m/min, 60 min/d)\                                                                                     
                                                                             group (HE) one a day\                                                                                     
                                                                             for 20 days                                                                                               

  Orthotopic    Female\          4T1 cell                       Running      voluntary exercise four\        -Tumor growth                     \- Beneficial effects of voluntary\     12
                BALB/c                                                       weeks;\                                                           exercise on breast cancer\              
                                                                             170.45±47.5 km and\                                               progression                             
                                                                             17.45±1.8 m.min-1,                                                                                        

  Orthotopic    BALB/cBy         4T1 cell                       Running      Using the wheel running:\       -Tumor growth                     -Running longer distances is\           13
                                                                             The running group\                                                associated with\                        
                                                                             ran an average daily\                                             decreased breast tumor burden\          
                                                                             distance of 4.89 ± 1.73\                                          in old mice                             
                                                                             km over 60 days prior to\                                                                                 
                                                                             4T1 tumor cell injection,\                                                                                
                                                                             and 2.38 ± 1.51 km over\                                                                                  
                                                                             30 days after tumor cell\                                                                                 
                                                                             injection                                                                                                 

  Xenograft     Female\          MCF-7 cell\                    Running      Using the wheel\                -Gene expression                  -Exercise decrease the IL-\             14
                BALB/c           (ER^-^, PR^-^, HER2^-^)                     running: 18 m/min for\                                            6, IL-18, TNF-a, CRP mRNA\              
                                                                             30 min for days per 12\                                           expression                              
                                                                             weeks                                                                                                     

  Transgenic\   FVB/NJ\          Genetically predisposed\       Running      Voluntary wheel running\        -Voluntary physical\              -C2(1)/SV40Tag mice \< FVB/\            15
  mice          C3(1)/SV40Tag    to develop\                                 : 1 h/day, 6 days/week\         activity (Running\                N mice\                                 
                                 breast cancer                               for 20 weeks                    distance/ Speed)\                 C2(1)/SV40Tag mice \> C2(1)/\           
                                                                                                             Tumor size                        SV40Tag + exercise                      

  Transgenic\   p53-deficient\   Genetically predisposed\       Running      1\) voluntary wheel running\    -p53 expression\                  -Con = TREX1 =TREX2 / Con\              16
  mice          (p53+/−):\       to develop\                                 Con-WHL, WHL\                   \                                 -WHL = WHL\                             
                MMTV-Wnt-1       breast cancer                               (exercise)\                     -Incidence\                       -Con\<TREX1=TREX2 / Con-\               
                                                                             \                               \                                 WHL \< WHL\                             
                                                                             2) non-Voluntary wheel\         -Multiplicity & survival          -Con\>TREX1=TREX2 / Con-\               
                                                                             running : Untreated\                                              WHL \< WHL                              
                                                                             group, 20 m/min\                                                                                          
                                                                             (TREX1), 24 m/min\                                                                                        
                                                                             (TREX2) for 5 days /\                                                                                     
                                                                             weeks                                                                                                     

  Orthotopic    Athymic          MDA-MB-231 cell                Running      Voluntary wheel running\        \- Survival\                      \- Con = Exercise\                      17
                                                                             running distance range\         -VEGF\                            - VEGF expression: Con\                 
                                                                             \~4 to \~6 km/day for 15\       -HIF-1alpha expression\           (48.6 pg/ml \> Exercise (47.0\          
                                                                             weeks                           -tumor metabolism                 pg/ml)\                                 
                                                                                                                                               - HIF-alpha expression: Con\            
                                                                                                                                               (5.4.%l \> Exercise (11.4%)\            
                                                                                                                                               Con (0.0.34 mmol/g) \< Exercise\        
                                                                                                                                               (0.42 mmol/g)                           

  Transgenic\   MMTV-PyMT\       Genetically predisposed\       Running      Voluntary wheel running         -Tumor growth\                    -Con \> Exercise\                       18
  mice          Tg               to develop\                                                                 \                                 \                                       
                                 breast cancer                                                               -Heart mass / Spleen\             -Con \< Exercise\                       
                                                                                                             mass\                             -CCL22 : Con\> Exercise\                
                                                                                                             -cytokine expression              CXCR4: Con \<Exercise                   

  Orthotopic    Female\          4T1 cell                       Running      Treadmill running\              -Carbohydrate oxidation\          -Decrease the carbohydrate\             19
                BALB/c                                                       progressive time (10-15\        \                                 oxidation in Exercise group\            
                                                                             min) and Speed (8-12\           -Gene expression                  \                                       
                                                                             m/min) for 8 weeks                                                -Up-regulated Ldha, HKII, glut\         
                                                                                                                                               1, HIF-1a, Mtor, p53, Lats2\            
                                                                                                                                               expression                              

  Xenograft     Female\          MC4-L2 cell\                   Running      6-18 m/min for 20-30\           -Gene expression                  The lowest level of IL-6,\              20
                BALB/c           (ER+)                                       min for 4 weeks                                                   VEGF                                    

  Xenograft     Female\          4T1 cell                       Running      Endurance-trained for\          -Tumor growth\                    -Exercise has -17% growth\              21
                BALB/c                                                       8 weeks;\                       \                                 rate, 24% long survival\                
                                                                             mice exercised 5 days a\        \                                 \                                       
                                                                             week, for 8 consecutive\        \                                 - 2- folds CD8+/FoxP3+\                 
                                                                             weeks\                          -Gene expression                  (Endurance exercise enhances\           
                                                                             (In the 8th and final\                                            antitumor immune efficacy)              
                                                                             week the mice ran for\                                                                                    
                                                                             26 min a day, spending\                                                                                   
                                                                             1 min at 6 m/min, 1 min\                                                                                  
                                                                             at 8 m/min, 22 min at\                                                                                    
                                                                             10 m/min, and 2 min\                                                                                      
                                                                             12 m/min.)                                                                                                

  Xenograft     Female\          4T1 cell                       Running      Using the treadmill;\           -Gene expression                  -Anti-inflammation : IL-10/\            22
                BALB/c                                                       After acclimation, 5 m/\                                          TNF-α ratio and IL-15 expression        
                                                                             min for 5 min., 10 m/\                                                                                    
                                                                             min. for 5 min., 15 m/\                                                                                   
                                                                             min. for 5 min., and\                                                                                     
                                                                             20 m/min. for 45 min.,\                                                                                   
                                                                             which is equivalent to\                                                                                   
                                                                             70% VO2 peak .\                                                                                           
                                                                             The exercise intensity\                                                                                   
                                                                             was gradually increased\                                                                                  
                                                                             each week for 2 weeks\                                                                                    
                                                                             \                                                                                                         

  Xenograft     Female\          4T1 cell                       Swimming     Swim training 5 days/\          -Gene expression                  -Th1 systemic response ;\               23
                BALB/c                                                       week for 4 weeks                                                  -Gata3 and Foxp3                        

  Xenograft     Female\          4T1 cell                       Running      4 weeks of high-intensity\      -Tumor growth\                    HIIT is associated with a\              24
                BALB/c                                                       interval training (HIIT)\       -Gene expression                  reduced risk of cancer-related\         
                                                                             and saffron aqueous\                                              muscle wasting; SAE enhances\           
                                                                             extract (SAE) supplementation                                     the improvement of muscle\              
                                                                                                                                               loss and apoptotic indices              

  Xenograft     Female\          MC4-L2 cell                    Running      Treadmill\                      -Gene expression                  -miR-21 pathways; reduced\              25
                Balb/c                                                       16--18 m/min, 0%\                                                 IL-6 levels, NF-kB and STAT3\           
                                                                             grade, 10--14 min, 5\                                             expressions & up-regulated\             
                                                                             days/week for 5 weeks                                             TPM1 and PDCD4 expressions              

  Xenograft     Female\          EO771 breast\                  Running      Reached maximum\                -Tumor hyposia,\                  unknown                                 26
                C57BL/6          tumor cell                                  ethical size in wheel\          perfusion, vascularity\                                                   
                                                                             running (8 km per day)          and proliferation                                                         

  Xenograft     Athymic          MDA-MB231 cell                 Running      Voluntary exercise;\            -Tumor growth                     -Inhibiting the growth of carcinomas    27
                                                                             The five-week period\                                                                                     
                                                                             ranged from \< 1\                                                                                         
                                                                             to 7.9 miles/day                                                                                          

  Chemical\     Female Balb/c    7,12-dimethylbenzanthracene\   Swimming     physical training of\           -Gene expression                  -Reduced Th1 cytokine\                  28
  induced\                       (1 mg/ml weekly\                            swimming in\                                                      increasing the Th2 cytokines\           
  mouse\                         for 6 weeks)                                water (30 ± 4°C) for 45\                                          and Treg cells                          
  model                                                                      min\                                                                                                      
                                                                             (5 times per week for 8\                                                                                  
                                                                             weeks)                                                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ER: estrogen receptor, PR: progesterone receptor, HER2: receptor tyrosine-protein kinase erbB-2, PTEN: Phosphatase and tensin homolog, APOE: apolipoprotein E, FVB: Friend leukemia virus B, ANKRD1: Ankyrin repeat domain protein, CTGF: connective tissue growth factor, PI3K: phosphoinosidied 3-kinase, AKT: protein kinase B, ERK: extracellular signal regulated kinase, IL: interleukin, TNF-α: tumor necrosis factor -- α, CRP : C-eactive protein, VEGF: vascular endothelial growth factor, HIF-1 α: hypoxia-inducible factor 1- α, CCL2: C-C motif chemokine ligand 2, CXCR4: C-XC chemokine receptor type 4, Ldha: lacate dehydrogenase A, HKII: hexokinase II, Glut 1: glucose transporter 1, Mtor : mammalian target of rapamycin, Lats2: large tumor suppressor kinase 2, CD8: cluster of differentiation 8, FoxP3: forkhead box P3, Gata3: GATA binding protein 3, Th : T helper cell, TPM1: tropomyosin alpha-1chain, PDCD4: programmed cell death protein

Conventional breast cancer therapy {#PAN_2020_v24n2_22_sec1-1}
----------------------------------

Modern people often suffer from various diseases, which leads to death. In particular, the four major chronic diseases leading to death have been reported as cancer, diabetes, cardiovascular, and chronic lung diseases. According to the Cancer Society report, the most common cancer among women worldwide is breast cancer^[@PAN_2020_v24n2_22_B1]^. Furthermore, the most common types of cancer in Korean women were breast cancer (19.9%), thyroid cancer (18.8%), colorectal cancer (10.5%), gastric cancer (9.2%), lung cancer (7.3%), and stomach and liver cancers (3.7%) were investigated according to a survey posted on the National Cancer Information Center (NCIC)^[@PAN_2020_v24n2_22_B2]^.

Standard treatment methods such as various anti-cancer drugs and surgery are being developed, and alternative medical technologies for incurable diseases are also in development. Currently, there are four main ways of cancer treatments: 1) surgery, 2) chemotherapy, 3) radiation therapy, and 4) hormone therapy.

Prophylactic surgery suppresses the cancer progression by performing a biopsy for the purpose of diagnosis through surgery or removing the benign tumor completely. Surgery also prevents the spread of cancer to other cells in the body and helps relieve symptoms. Chemotherapy refers to the use of therapeutic agents for regulating hyperproliferative cells. Radiation therapy kills cancer cells by directly irradiating them. Hormone therapy that suppresses estrogen action is also used as a cancer treatment method, as breast cancer is affected by estrogen levels, unlike other cancers.

Exercise regulates the breast cancer in animal models by inhibiting carcinogenesis {#PAN_2020_v24n2_22_sec1-2}
----------------------------------------------------------------------------------

Disease increase over the last two decades may be due to a more westernized lifestyle, which is accompanied by excessive nutrition and lack of exercise^[@PAN_2020_v24n2_22_B3]^. Guidelines on cancer prevention are well known, and include recommendations for controlling metabolism, such as a balanced nutrient intake, eating vegetables, regulating vitamin intake, and controlling weight. Furthermore, exercise can prevent and treat various diseases, and in recent years, research on anti-cancer efficacy has been actively conducted.

Physical activities of Korean women are very low compared to women in other countries. Moreover, many women have adopted western food and a sedentary lifestyle, which has led to reduced voluntary exercise. The highest incidence of cancer among Korean women is breast cancer, and it has been suggested that breast cancer may be related to metabolic problems. Therefore, the effectiveness of exercise for the treatment or prevention of breast cancer should be investigated in future clinical studies.

An experimental laboratory animal is defined as an animal developed and improved for use in accordance with the purpose of test, diagnosis, education, research, and biological products in the research process. Among laboratory animals, primates such as *Callithrix jacchus* and *Macaca fascicularis* are most similar to humans; however, there exist issues regarding the ethics of conducting research using these animals. Rodents such as *Mus muculus*, *Rattus norvegicus*, and *Cavia porcellus* are the most commonly used experimental animals. In particular, *Mus muculus* has a genetic similarity with humans (approximately \>80%), and a biologically similar body structure, a short pregnancy period (19 - 21 days) is also advantageous for preclinical studies. Therefore, *Mus muculus* has been used as a knockout mouse, cancer model xenograft, orthotropic model, and chemically induced-disease model. To develop a mouse model of breast cancer, it is necessary to have experimental cells, and patient derived primary cells such as MCF-7 (ER+, PR+, HER2-), MDA-MD-231 (ER+, PR+, HER2-), MC4-L2 (ER+), E0771 (ER+) and 4T1 (ER-) ([Fig. 1](#PAN_2020_v24n2_22_F1){ref-type="fig"}).

![Breast cancer mouse models](PAN_2020_v24n2_22_f001){#PAN_2020_v24n2_22_F1}

The breast cancer animal model consists of chemically induced models, transgenic mice models, orthotopic mice models, and xenograft models. In the case of chemically induced breast cancer models, 7,12-dimethylbenzanthracene (DMBA; 1 mg/mL weekly, for six weeks) is injected subcutaneously into the side of the abdomen. Poly-aromatic structure of lipophilic molecule, DMBA has high carcinogen activity in the breast. To evaluate tumor progression, mice are established with genetic modifications that target the oncogene, such as simian virus 40 (SV40) T antigens and polymer middle T antigen (PyMT). In the establishment of mice models by injection with breast cancer cells, mice are mainly used in the study of tumor biology and pharmacology, as these models retain the biological properties of cancer. Breast cancer cells are injected into the mammary fat pad of host mice to obtain orthotropic models. In this case, the number of cells used is appropriate (1 x 10^5^ to 1 x 10^6^/mouse), and cancer cells injected into the mouse organs exhibit properties similar to breast cancer generated in the human body over time, and can be correlated to metastatic cancer. To develop a xenograft model, cells (1 x 10^6^ to 1 x 10^7^/mouse) are injected subcutaneously into the dorsal side of the mouse.

Using these various animal models, studies on the beneficial effect of exercise against tumor growth and tumorigenesis of breast cancer have been extensively reported ([Fig. 2](#PAN_2020_v24n2_22_F2){ref-type="fig"}; [Table 1](#PAN_2020_v24n2_22_T1){ref-type="table"}). Tumors are defined as transformed cells that undergo abnormal or rapid proliferation, beyond normal regulatory functions, in the organism. Tumors are divided into two types: benign neoplasms and carcinomas. Benign neoplasms have a relatively slow growth rate, and do not penetrate or spread into other tissues. In contrast, carcinomas rapidly grow, and invade other tissues and metastasize. The process of tumor development by carcinogenesis is a multi-step process. The first stage is initiation, where normal cellular DNA is attacked by carcinogens, leading to genetic modification and irreversible mutations. The second stage is promotion, wherein cell proliferation is actively performed to maintain and promote the population of mutant cells to counter immune response in vivo as it eliminates abnormal cells. The third step is progression, the process of increasing the characteristics of a malignant tumor by converting it from a benign tumor to a malignant tumor. In the process of tumor development, the morphology and function of normal cells are altered by genetic modification through internal or external stimulants. External factors include chemical carcinogens such as smoking, physical stimuli such as radiation, and RNA tumor viruses such as HTLV-1 virus. Internal factors involved in the mutation of the target gene include oncogene and tumor suppressor genes. Tumor suppressor genes include TGF-β, E-Cadherin, NF-1, PTEN, SAMD2, SMAD4, and p53, and regulate cell population through apoptosis and proliferation. Oncogene mutation targets are cell cycle regulatory genes such as cyclin D1, Her2, and K-ras. Many preclinical studies suggest that the beneficial effect of exercise training in cancer progression is brought about by direct regulation of intertumoral factors, i.e., tumor growth rate, metastasis, and tumor immunogenicity ([Table 1](#PAN_2020_v24n2_22_T1){ref-type="table"}).

![Exercise regulates carcinogenesis by regulating the microenvironment](PAN_2020_v24n2_22_f002){#PAN_2020_v24n2_22_F2}

[Table 1](#PAN_2020_v24n2_22_T1){ref-type="table"} summarizes the research methods used for controlling the intensity of exercise that underlies the exercise protocols using wheel running, treadmill, and swimming. These preclinical studies clearly demonstrate a decrease in tumor growth rate caused by exercise. Interestingly, Berrueta et al. demonstrated that exercise, such as stretching for 10 minutes once a day over a four-week period, reduced tumor size in a breast cancer model by 50%^[@PAN_2020_v24n2_22_B5]^. In other studies, voluntary exercise also inhibited tumor size and tumor growth ^[@PAN_2020_v24n2_22_B4],[@PAN_2020_v24n2_22_B7],[@PAN_2020_v24n2_22_B9],[@PAN_2020_v24n2_22_B12],[@PAN_2020_v24n2_22_B13],[@PAN_2020_v24n2_22_B15],[@PAN_2020_v24n2_22_B16]-[@PAN_2020_v24n2_22_B18],[@PAN_2020_v24n2_22_B27]^. Moreover, more studies have been conducted on endurance exercise than resistance exercise; endurance exercise has shown anti-tumor effects^[@PAN_2020_v24n2_22_B6],[@PAN_2020_v24n2_22_B8],[@PAN_2020_v24n2_22_B10],[@PAN_2020_v24n2_22_B11],[@PAN_2020_v24n2_22_B21],[@PAN_2020_v24n2_22_B22]^. Taken together, these data suggest that the anti-cancer activity of the exercise protocols is involved in endurance and moderate-intensity exercise.

If so, which mechanism of exercise showed an anti-cancer effect? Results strongly suggest that exercise inhibits epigenetic modification of tumor cells, but enhances apoptosis and immune suppression^[@PAN_2020_v24n2_22_B29]^. Reactive oxygen species (ROS) perform signal transduction in vivo; however, excessive production can cause oxidative stress, which leads to cancer^[@PAN_2020_v24n2_22_B30]^. Moderate intensity exercise can regulate ROS and biological signaling in vivo^[@PAN_2020_v24n2_22_B31]^. It is likely that exercise is related to the regulation of the reactive oxygen species (ROS)-involved microenvironment of cancer^[@PAN_2020_v24n2_22_B32]^. Therefore, these studies also suggest that controlling ROS a potential mechanism for the treatment of cancer^[@PAN_2020_v24n2_22_B33]^.

However, this claim raises further questions as to why exercise is closely related to change in the microenvironment of cancer. One possible belief is that exercise can exert anti-cancer effects by solving problems that arise during metabolic processes. During carcinogenesis, most tumor cells exert cell growth signaling pathway via glucose metabolic reprograming^[@PAN_2020_v24n2_22_B34]^. Recent study suggests that effective anti-cancer effect could be related to the regulation of metabolic syndrome^[@PAN_2020_v24n2_22_B35]^. The results supporting these claims are as follows: First, exercise can lead to activation of natural killer cell, lymphocyte, consequently resulting in the regulation of the tumor growth and metastasis^[@PAN_2020_v24n2_22_B36]^. In addition, exercise attenuates tumorigenesis and tumor progression^[@PAN_2020_v24n2_22_B37]^. Next, the ketone diet (KD) is characterized by high fat, adequate protein, and very low carbohydrate compositions. Some studies have reported that the physiological phenomena caused by exercise or fasting are very similar to physiological conditions observed in the KD^[@PAN_2020_v24n2_22_B38]^. Various preclinical studies have shown that exercise or the KD displays anti-cancer efficacy^[@PAN_2020_v24n2_22_B39],[@PAN_2020_v24n2_22_B40]^. Taken together, a possible hypothesis is that exercise-binding KD modulates metabolic dysfunction and causes internal factors, which involved in the mutation of the target gene such as ROS generation and tumor-suppressor gene mutations, thereby suggesting its potential as a cancer therapeutic.

However, the anti-cancer effects of KD and exercise can be contradictory. Acute exercise did not change tumor formation, but continuous steady aerobic exercise displayed effective anticancer effects. The general view presented in many studies is that exercise exerts an anti-cancer effect by reducing the size of tumors, promoting energy metabolism, and increasing immune activity by constant exercise. Therefore, further studies should investigate that find and apply an appropriate energy source for exercise that show anticancer efficacy.

CONCLUSION {#PAN_2020_v24n2_22_sec2}
==========

Various preclinical studies have shown that exercise weakens tumor growth and tumor development. Moreover, these studies suggest that mice bearing breast cancer exhibited anti-cancer effects by increasing immune responses and anti-inflammatory factor levels through acclimation of increased exercise intensity every week. Thus, continuous exercise can have potential medical benefits as a prevention or therapeutic method for breast cancer. To facilitate this research, researchers need to study the etiological mechanisms that rely on clinical features with underlying pathological features of the disease, as well as based on mechanisms not necessarily present in patients. For example, using animal models to discover new treatments for a variety of diseases is an essential element in discovering new therapeutic targets and performing drug testing at the preclinical stage.
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